4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Minerva Neurosciences, Inc. (NERV) operates in the Biotechnology industry and is headquartered in Burlington, United States with about 7 employees. Its market capitalization is roughly $204 million. In the fiscal year ended 2025-12-31, NERV reported $0M in revenue and ($293M) in net income.
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($15M) | ($22M) | ($23M) | ($25M) | — |
| Net Income | ($293M) | $1M | ($30M) | ($32M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($17M) | ($5M) | ($3M) | ($3M) | ($4M) | — |
| Net Income | ($125M) | ($284M) | ($3M) | ($3M) | ($4M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $98M | $37M | $57M | $55M | — |
| Total Liabilities | $239M | $63M | $85M | $75M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NERV viewer.
About TickerBase · Data methodology & sources